Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-27

Study Completion Date

2020-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc. In this clinical trial, the investigators aim to analyze the effect of nanofat grafting on treating androgenic alopecia in male.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Autologous Hair Follicle Derived Mesenchymal Stem Cell Suspension to Treat AGA

NCT05659095

Hair Transplantation

COMPLETED NA

Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia

NCT02154503

Androgenetic Alopecia

UNKNOWN PHASE1

Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation

NCT07287579

Androgenic Alopecia

NOT_YET_RECRUITING NA

Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study

NCT05129800

Androgenetic Alopecia Hair Loss Alopecia

COMPLETED

Successful Treatment of Female Pattern Hair Loss With Injection of Nanofat With and Without Platelet-Rich Plasma

NCT07096323

Female Pattern Hair Loss

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will treat the hair loss area of a patient by processed nanofat grafting. The participants were asked to come back 1、3、6、9、12 months after treatment for further follow-up.

Before and after the treatment, the hair and follicular will be assessed subjectively by satisfaction assessment, dermatoscope.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Androgenic Alopecia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

processed Nanofat grafting

processed autologous Nanofat will be injected into the area of the scalp with androgenic alopecia.

Group Type EXPERIMENTAL

Nanofat grafting

Intervention Type PROCEDURE

hair loss area will be treated by processed autologous Nanofat grafting

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nanofat grafting

hair loss area will be treated by processed autologous Nanofat grafting

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male patients with androgenic alopecia aging from 18 to 50.
* No scars and wounds on the alopecia area.
* No skin disease or serious cardiovascular disease.
* Preoperative examinations remain healthy.

Exclusion Criteria

* Serious chronic heart, liver, kidney, blood system disease
* Allergic diseases, skin inflammation or wounds
* Alopecia but not androgenic alopecia
* Acute or chronic infection
* Take anticoagulant drugs
* Active vitiligo, psoriasis, systemic lupus erythematosus

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes